Filing Details

Accession Number:
0001192482-11-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-17 18:43:03
Reporting Period:
2011-02-15
Filing Date:
2011-02-17
Accepted Time:
2011-02-17 18:43:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1497725 Quaker Bioventures Ii Lp C/O Quaker Bioventures Ii, L.p.
2929 Arch Street
Philadelphia PA 19104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-15 75,000 $5.07 4,784,438 No 4 S Direct
Common Stock Disposition 2011-02-16 75,000 $5.08 4,709,438 No 4 S Direct
Common Stock Disposition 2011-02-17 6,787 $5.08 4,702,651 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average sales price for price increments ranging from $5.05 to $5.18.
  2. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  3. The securities are deemed to be beneficially owned by Quaker BioVentures II, L.P. and Quaker BioVentures Capital II, LLC. Quaker BioVentures Capital II, L.P. is the general partner of Quaker BioVentures II, L.P. Quaker BioVentures Capital II, LLC is the general partner of Quaker BioVentures Capital II, L.P.
  4. Represents the weighted average sales price for price increments ranging from $5.05 to $5.10.
  5. Represents the weighted average sales price for price increments ranging from $5.05 to $5.10.